ArticleCancer research communications2026

A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor-Positive Metastatic Breast Cancer.

Alberto A Gabizon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.